Predicting Clinical Resistance to Gleevec Treatment by in vitro Applied Stable Isotope-based Dynamic Metabolic Profiling
Laszlo G. Boros, Los Angeles Biomedical Research Institute at UCLA and SIDMAP, LLC, speaking at Advances in Metabolic Profiling 2005
Metabolic Profiles and Biomarkers for Detection and Prediction of Drug Effects
Hans Senn of F. Hoffmann-La Roche AG speaking at Advances in Metabolic Profiling 2005.
Predicting the Safety of FDA Regulated Products with Metabolomics
Laura Schnackenberg, Center for Metabolomics Research, speaks at Advances in Metabolic Profiling 2005.
The Application of Metabolic Profiling Techniques in Biomarker Discovery in Drug R&D
Dr. Ina Schuppe Koistinen, AstraZeneca R&D speaking at Advances in Metabolic Profiling 2005
Metabolomics as a Tool for Biomarker Discovery
Dr. Chris Beecher, Vice President of Biochemistry and Technology, Metabolon, Inc., speaking at Advances in Metabolic Profiling 2005
|<< || 2 3 4 5 6 7 8 ||>>|
|Showing Results 71 - 75 of 75|